Sunshine Notice-September 4, 2019 Public Hearing, 40106-40107 [2019-17449]

Download as PDF 40106 Federal Register / Vol. 84, No. 156 / Tuesday, August 13, 2019 / Notices braille, large print), please notify Kimberly Meyer-Chambers, NRC Disability Program Manager, at 301– 287–0739, by videophone at 240–428– 3217, or by email at Kimberly.MeyerChambers@nrc.gov. Determinations on requests for reasonable accommodation will be made on a case-by-case basis. Members of the public may request to receive this information electronically. If you would like to be added to the distribution, please contact the Nuclear Regulatory Commission, Office of the Secretary, Washington, DC 20555 (301– 415–1969), or by email at Wendy.Moore@nrc.gov or Tyesha.Bush@ nrc.gov. The NRC is holding the meetings under the authority of the Government in the Sunshine Act, 5 U.S.C. 552b. Dated at Rockville, Maryland, this 8th day of August, 2019. For the Nuclear Regulatory Commission. Denise L. McGovern, Policy Coordinator, Office of the Secretary. [FR Doc. 2019–17378 Filed 8–9–19; 11:15 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION Advisory Committee on the Medical Uses of Isotopes: Meeting Notice U.S. Nuclear Regulatory Commission. ACTION: Notice of meeting. jspears on DSK3GMQ082PROD with NOTICES AGENCY: The U.S. Nuclear Regulatory Commission (NRC) will convene a meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on September 10–11, 2019. A sample of agenda items to be discussed during the public session includes: (1) An update on medical-related events; (2) a discussion of the ACMUI’s recommendations and comments on the draft Xcision® GammaPod Licensing Guidance; (3) a discussion on the status of emerging technologies licensed under Title 10 Code of Federal Regulations (10 CFR) Part 35.1000; (4) a discussion of the ACMUI’s recommendations related to the appropriateness of the required medical event reporting in accordance with 10 CFR 35.3045; (5) a presentation from the National Nuclear Security Administration on their initiative to reduce the use of radioactive materials; (6) a discussion of the ACMUI’s recommendations for improving the ACMUI’s institutional memory; (7) a discussion of the ACMUI’s recommendations and comments regarding the NRC’s policy decision related to infiltrations and medical event reporting; (8) an update on the VerDate Sep<11>2014 17:51 Aug 12, 2019 Jkt 247001 NRC staff’s evaluation of training and experience requirements for radiopharmaceuticals requiring a written directive; and (9) a discussion on the U.S. Pharmacopeia General Chapter <825>. The agenda is subject to change. The current agenda and any updates will be available at http:// www.nrc.gov/reading-rm/doccollections/acmui/meetings/2019.html or by emailing Ms. Kellee Jamerson at the contact information below. Purpose: Discuss issues related to 10 CFR part 35 Medical Use of Byproduct Material. Date and Time for Open Sessions: September 10, 2019, from 8:30 a.m. to 2:45 p.m. and September 11, 2019, from 8:30 a.m. to 11:30 a.m. Eastern Standard Time (EST). Date and Time for Closed Session: September 10, 2019, from 7:30 a.m. to 8:30 a.m. and 2:45 p.m. to 5:00 p.m. EST. These sessions will be closed on September 10, 2019, for badging and enrollment of new members to the ACMUI and for required annual training, respectively. Address for Public Meeting: U.S. Nuclear Regulatory Commission, Two White Flint North Building, Room T– 2D30, 11545 Rockville Pike, Rockville, Maryland 20852. Public Participation: Any member of the public who wishes to participate in the meeting in person or via phone should contact Ms. Jamerson using the information below. The meeting will also be webcast live at https:// video.nrc.gov/. Contact Information: Ms. Kellee Jamerson, email: Kellee.Jamerson@ nrc.gov, telephone: (301) 415–7408. Conduct of the Meeting Christopher J. Palestro, M.D. will chair the meeting. Dr. Palestro will conduct the meeting in a manner that will facilitate the orderly conduct of business. The following procedures apply to public participation in the meeting: 1. Persons who wish to provide a written statement should submit an electronic copy to Ms. Jamerson using the contact information listed above. All submittals must be received by September 5, 2019, three business days before the meeting, and must pertain to the topics on the agenda for the meeting. 2. Questions and comments from members of the public will be permitted during the meeting, at the discretion of the Chairman. 3. The draft transcript and meeting summary will be available on ACMUI’s website http://www.nrc.gov/reading-rm/ doc-collections/acmui/meetings/ 2019.html on or about October 25, 2019. PO 00000 Frm 00087 Fmt 4703 Sfmt 4703 4. Persons who require special services, such as those for the hearing impaired, should notify Ms. Jamerson of their planned attendance. This meeting will be held in accordance with the Atomic Energy Act of 1954, as amended (primarily Section 161a); the Federal Advisory Committee Act (5 U.S.C. App); and the Commission’s regulations in Title 10 of the Code of Federal Regulations, Part 7. Dated at Rockville, Maryland, this 8th day of August 2019. For the U.S. Nuclear Regulatory Commission. Russell E. Chazell, Federal Advisory Committee Management Officer. [FR Doc. 2019–17267 Filed 8–12–19; 8:45 am] BILLING CODE 7590–01–P OVERSEAS PRIVATE INVESTMENT CORPORATION Sunshine Notice—September 4, 2019 Public Hearing 1:00 p.m., Wednesday, September 4, 2019. PLACE: Offices of the Corporation, Twelfth Floor Board Room, 1100 New York Avenue NW, Washington, DC. STATUS: Hearing OPEN to the Public at 1:00 pm. MATTERS TO BE CONSIDERED: This will be a Public Hearing, held in conjunction with each meeting of OPIC’s Board of Directors, to afford an opportunity for any person to present views regarding the activities of the Corporation. Individuals wishing to address the hearing orally must provide advance notice to OPIC’s Corporate Secretary no later than 5 p.m., Tuesday, August 27, 2019. The notice must include the individual’s name, title, organization, address, and telephone number, and a concise summary of the subject matter to be presented. Oral presentations may not exceed ten (10) minutes. The time for individual presentations may be reduced proportionately, if necessary, to afford all participants who have submitted a timely request an opportunity to be heard. Participants wishing to submit a written statement for the record must submit a copy of such statement to OPIC’s Corporate Secretary no later than 5 p.m. Tuesday, August 27, 2019. Such statement must be typewritten, double spaced, and may not exceed twenty-five (25) pages. Upon receipt of the required notice, OPIC will prepare an agenda, which will be available at the hearing, that TIME AND DATE: E:\FR\FM\13AUN1.SGM 13AUN1 Federal Register / Vol. 84, No. 156 / Tuesday, August 13, 2019 / Notices identifies speakers, the subject on which each participant will speak, and the time allotted for each presentation. A written summary of the hearing will be compiled, and such summary will be made available, upon written request to OPIC’s Corporate Secretary, at the cost of reproduction. Written summaries of the projects to be presented at the September 11, 2019, Board meeting will be posted on OPIC’s website. CONTACT PERSON FOR MORE INFORMATION: Information on the hearing may be obtained from Catherine F. I. Andrade at (202) 336–8768, via facsimile at (202) 408–0297, or via email at Catherine.Andrade@opic.gov. Dated: August 9, 2019. Catherine F. I. Andrade, OPIC Corporate Secretary. [FR Doc. 2019–17449 Filed 8–9–19; 4:15 pm] BILLING CODE 3210–01–P SECURITIES AND EXCHANGE COMMISSION [Release No. 34–86589; File No. SR–DTC– 2018–010] Self-Regulatory Organizations; The Depository Trust Company; Notice of Filing Amendment Nos. 1 and 2, and Order Granting Accelerated Approval of a Proposed Rule Change, as Modified by Amendment Nos. 1 and 2, To Amend the Settlement Guide Procedures To Provide Status Information for Institutional Transactions to a Matching Utility August 7, 2019. On November 29, 2018, The Depository Trust Company (‘‘DTC’’), filed with the Securities and Exchange Commission (‘‘Commission’’) a proposed rule change, pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934 (‘‘Act’’) 1 and Rule 19b–4 thereunder,2 to allow DTC to share status information with matching utilities (SR–DTC–2018–010). The proposed rule change was published for comment in the Federal Register on December 12, 2018.3 In response, the Commission received one comment letter on the proposed rule change.4 On December 26, 2018, the 1 15 U.S.C. 78s(b)(1). CFR 240.19b–4. 3 Securities Exchange Act Release No. 84751 (December 7, 2018), 83 FR 63948 (December 12, 2018) (SR–DTC–2018–010) (‘‘Notice’’). 4 Letter from Mari-Anne Pisarri, Pickard Djinis and Pisarri LLP, dated January 2, 2019, to Eduardo A. Aleman, Assistant Secretary, Commission, available at https://www.sec.gov/comments/sr-dtc2018-010/srdtc2018010-4842066-177179.pdf (‘‘SS&C Letter I’’). jspears on DSK3GMQ082PROD with NOTICES 2 17 VerDate Sep<11>2014 17:51 Aug 12, 2019 Jkt 247001 Commission extended the time period within which to approve the proposed rule change, disapprove the proposed rule change, or institute proceedings to determine whether to approve or disapprove the proposed rule change to March 12, 2019.5 On March 11, 2019, the Commission issued an order instituting proceedings under Section 19(b)(2)(B) of the Act 6 to determine whether to approve or disapprove the proposed rule change (‘‘OIP’’).7 The Commission received additional comments on the proposal in response to the OIP.8 On June 5, 2019, the Commission designated a longer period for Commission action on the proceedings to determine whether to approve or disapprove the proposed rule change.9 On June 28, 2019, DTC filed Amendment No. 1 to the proposed rule change to provide status information to a matching utility even if that matching utility did not submit a transaction to DTC.10 On August 5, 2019, DTC filed Amendment No. 2 to the proposed rule change to delay the implementation timeframe of the proposal to until DTC has submitted a subsequent fee filing.11 5 Securities Exchange Act Release No. 84954 (December 26, 2018), 84 FR 873 (January 31, 2019) (SR–TC–2018–010). 6 15 U.S.C. 78s(b)(2)(B)(ii). 7 Securities Exchange Act Release No. 85288 (March 11, 2019), 84 FR 9565 (March 15, 2019) (SR– DTC–2018–010). 8 Letter from John F. Abel, Executive Director, Settlement and Asset Services, Depository Trust and Clearing Corporation, dated July 1, 2019, to Vanessa Countryman, Acting Secretary, Commission, available at https://www.sec.gov/ comments/sr-dtc-2018-010/srdtc2018010-5749578186788.pdf (‘‘DTC Letter II’’); Letter from MariAnne Pisarri, Pickard Djinis and Pisarri LLP, dated April 15, 2019, to Vanessa Countryman, Acting Secretary, Commission, available at https:// www.sec.gov/comments/sr-dtc-2018-010/ srdtc2018010-5364127-184089.pdf (‘‘SS&C Letter II’’); and Letter from Murray Pozmanter, Managing Director, Head of Clearing Agency Services and Global Operations, Depository Trust and Clearing Corporation, dated March 26, 2019, to Brent J. Fields, Secretary, Commission, available at https:// www.sec.gov/comments/sr-dtc-2018-010/ srdtc2018010-5224494-183708.pdf (‘‘DTC Letter I’’). 9 Securities Exchange Act Release No. 88037 (June 5, 2019), 84 FR 27172 (June 11, 2019) (SR– DTC–2018–010). 10 DTC submitted a courtesy copy of Amendment No. 1 to the proposed rule change through the Commission’s electronic public comment letter mechanism. Accordingly, Amendment No. 1 to the proposed rule change has been publicly available on the Commission’s website at https:// www.sec.gov/comments/sr-dtc-2018-010/ srdtc2018010.htm since July 2, 2019. 11 DTC submitted a courtesy copy of Amendment No. 2 to the proposed rule change through the Commission’s electronic public comment letter mechanism. Accordingly, Amendment No. 2 to the proposed rule change has been publicly available on the Commission’s website at https:// www.sec.gov/comments/sr-dtc-2018-010/ srdtc2018010-5914689-188969.pdf since August 6, 2019. PO 00000 Frm 00088 Fmt 4703 Sfmt 4703 40107 The Commission is publishing this notice to solicit comment on Amendment Nos. 1 and 2 from interested persons and to approve the proposed rule change, as modified by Amendment Nos. 1 and 2 (hereinafter, ‘‘Proposed Rule Change’’), on an accelerated basis. I. Description of the Proposed Rule Change Background DTC proposes to amend the procedures, set forth in the DTC Settlement Service Guide (‘‘Settlement Guide’’),12 to allow DTC to provide status information (‘‘Status Information’’) for institutional transactions in eligible securities (‘‘Institutional Transactions’’) 13 to an entity providing a matching service (‘‘Matching Utility’’),14 as described below. In accordance with the Settlement Guide, for a Matching Utility to establish and maintain a connection with DTC the Matching Utility must be able to balance with DTC in an automated way 15 and communicate transactions to and from DTC with information required though mandated fields in order to provide DTC with data necessary for it to be able to process a transaction.16 The submission of an 12 Each capitalized term not otherwise defined herein has its respective meaning as set forth in the Rules, By-Laws and Organization Certificate of The Depository Trust Company (‘‘Rules’’), available at http://www.dtcc.com/legal/rules-andprocedures.aspx, and the Settlement Service Guide, available at http://www.dtcc.com/∼/media/Files/ Downloads/legal/service-guides/Settlement.pdf (‘‘Settlement Guide’’). 13 DTC defines an Institutional Transaction as a securities transaction between a broker-dealer and its institutional customer (e.g., sell-side firms, buyside institutions, and custodians). Notice, supra note 3, 83 FR at 63948. 14 A ‘‘matching service’’ is defined in the Settlement Guide as an electronic service to match trade information, centrally, between a brokerdealer and its institutional customer. 15 For each Matching Utility interfacing with DTC, DTC requires the Matching Utility to deliver a daily message on each business day shortly after noon from the Matching Utility with their accepted item counts of institutional delivery and ID Net transaction totals for transactions settling the previous day. Settlement Guide, supra note 12 at 35. DTC’s system will compare the totals from the Matching Utility to its accepted item counts. Id. If the totals match, an ‘‘acknowledged balance’’ balance file will be sent to the Matching Utility. Id. If the totals do not match, DTC will respond with the list of control numbers received from the Matching Utility for transactions that settled on the previous day, along with their respective transaction types for the originating Matching Utility to compare. Id. 16 Settlement Guide, supra note 12 at 35. The mandated fields for this purpose are the transaction control number (‘‘Control Number’’), DTC receiver and deliverer account numbers, CUSIP, message type, share quantity, market type, buy-sell E:\FR\FM\13AUN1.SGM Continued 13AUN1

Agencies

[Federal Register Volume 84, Number 156 (Tuesday, August 13, 2019)]
[Notices]
[Pages 40106-40107]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-17449]


=======================================================================
-----------------------------------------------------------------------

OVERSEAS PRIVATE INVESTMENT CORPORATION


Sunshine Notice--September 4, 2019 Public Hearing

TIME AND DATE: 1:00 p.m., Wednesday, September 4, 2019.

PLACE:  Offices of the Corporation, Twelfth Floor Board Room, 1100 New 
York Avenue NW, Washington, DC.

STATUS:  Hearing OPEN to the Public at 1:00 pm.

MATTERS TO BE CONSIDERED:  This will be a Public Hearing, held in 
conjunction with each meeting of OPIC's Board of Directors, to afford 
an opportunity for any person to present views regarding the activities 
of the Corporation.
    Individuals wishing to address the hearing orally must provide 
advance notice to OPIC's Corporate Secretary no later than 5 p.m., 
Tuesday, August 27, 2019. The notice must include the individual's 
name, title, organization, address, and telephone number, and a concise 
summary of the subject matter to be presented.
    Oral presentations may not exceed ten (10) minutes. The time for 
individual presentations may be reduced proportionately, if necessary, 
to afford all participants who have submitted a timely request an 
opportunity to be heard.
    Participants wishing to submit a written statement for the record 
must submit a copy of such statement to OPIC's Corporate Secretary no 
later than 5 p.m. Tuesday, August 27, 2019. Such statement must be 
typewritten, double spaced, and may not exceed twenty-five (25) pages.
    Upon receipt of the required notice, OPIC will prepare an agenda, 
which will be available at the hearing, that

[[Page 40107]]

identifies speakers, the subject on which each participant will speak, 
and the time allotted for each presentation.
    A written summary of the hearing will be compiled, and such summary 
will be made available, upon written request to OPIC's Corporate 
Secretary, at the cost of reproduction.
    Written summaries of the projects to be presented at the September 
11, 2019, Board meeting will be posted on OPIC's website.

CONTACT PERSON FOR MORE INFORMATION:  Information on the hearing may be 
obtained from Catherine F. I. Andrade at (202) 336-8768, via facsimile 
at (202) 408-0297, or via email at [email protected].

     Dated: August 9, 2019.
Catherine F. I. Andrade,
OPIC Corporate Secretary.
[FR Doc. 2019-17449 Filed 8-9-19; 4:15 pm]
 BILLING CODE 3210-01-P